HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nonoxynol-9 Microbicidal Ineffectiveness Cited In JAMA Study, Editorial

This article was originally published in The Tan Sheet

Executive Summary

A recent study on nonoxynol-9 gel confirms its inadequacy as a microbicide and lends further proof of its suspected irritant effects, according to an editorial in the March 6 Journal of the American Medical Association

You may also be interested in...



Nonoxynol-9 Labeling Changes Under Discussion At FDA

Modifications of nonoxynol-9 (N-9) labeling are being considered by FDA, but the spermicide's OTC status appears to be safe for the time being

Vaginal Lubricants’ Ability To Kill HIV Merits Human Study – Researchers

Clinical trials testing the protective effect of three FDA-approved vaginal lubricants and preparations against HIV should be conducted in populations at high-risk for contracting the virus, University of Texas Medical Branch at Galveston researchers state

Columbia Labs Advantage-S Additional HIV Prevention Trials Unlikely

"It will be very difficult to conduct another study" on Advantage-S (nonoxynol-9) and HIV prevention after a Joint U.N. Program on HIV/AIDS trial produced negative results, Columbia Labs Chairman and CEO William Bologna asserted during a June 12 conference call.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS130630

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel